Company Primo Nutraceutical Srl with Fiscal Code 33567835
recorded a turnover of 2024 of
3.633,
with a net profit of
-840
and having an average number of employees of
- .
The company operates in the field of CAEN Ver.3: Intermedieri în comerţul cu amănuntul nespecializat; CAEN Ver.2: Comert cu amanuntul prin intermediul caselor de comenzi sau prin Internet; having the NACE code 4791.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Primo Nutraceutical Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
21.133
18.504
20.108
18.486
15.935
13.404
8.760
10.302
9.480
3.633
Total Income - EUR
21.133
18.504
20.108
18.486
15.935
13.404
8.760
10.302
9.480
3.633
Total Expenses - EUR
13.775
15.128
14.107
12.206
10.636
8.191
5.896
7.225
7.762
4.473
Gross Profit/Loss - EUR
7.358
3.376
6.001
6.280
5.299
5.213
2.864
3.077
1.718
-840
Net Profit/Loss - EUR
6.724
2.821
5.398
5.725
4.821
4.843
2.630
2.784
1.412
-840
Employees
0
1
1
0
0
0
0
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -61.5%, from 9.480 euro in the year 2023, to 3.633 euro in 2024.
The Net Profit decreased by -1.404 euro, from 1.412 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Primo Nutraceutical Srl
Financial Rating - PRIMO NUTRACEUTICAL SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Primo Nutraceutical Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Primo Nutraceutical Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Primo Nutraceutical Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Primo Nutraceutical Srl - CUI 33567835
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
6.341
8.881
13.960
20.589
25.226
25.700
27.203
29.964
31.613
30.667
Inventories
1.259
297
1.415
4.046
5.648
1.733
1.756
2.309
3.410
1.286
Receivables
0
0
0
14.714
15.601
16.110
15.151
24.701
26.240
29.164
Cash
5.082
8.584
12.545
1.829
3.977
7.857
10.297
2.953
1.963
216
Shareholders Funds
5.813
8.575
13.828
19.299
23.747
24.369
26.459
29.324
30.647
29.637
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
528
306
132
1.290
1.479
1.331
745
640
966
1.030
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4791 - 4791"
CAEN Financial Year
4791
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
30.667 euro in 2024 which includes Inventories of
1.286 euro, Receivables of
29.164 euro and cash availability of
216 euro.
The company's Equity was valued at
29.637 euro, while total Liabilities amounted to
1.030 euro.
Equity decreased by -839 euro, from 30.647 euro in 2023, to 29.637 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Primo Nutraceutical Srl